HETEROCYCLIC INDOLE DERIVATIVES AND MONO- OR DIAZAINDOLE DERIVATIVES
申请人:CHUGAI SEIYAKU KABUSHIKI KAISHA
公开号:EP1086950B1
公开(公告)日:2010-09-29
US6673797B1
申请人:——
公开号:US6673797B1
公开(公告)日:2004-01-06
US6875770B2
申请人:——
公开号:US6875770B2
公开(公告)日:2005-04-05
US7612070B2
申请人:——
公开号:US7612070B2
公开(公告)日:2009-11-03
Heterocyclic indole derivatives and mono- or diazaindole derivatives
申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:US06673797B1
公开(公告)日:2004-01-06
There is provided a compound represented by the
general formula (1):
wherein Het represents an optionally substituted heterocyclic group; A1 and A2 each independently represent —CH═, etc.; A3 represents —CH2—, etc.; R1 represents a 4-fluorophenyl group, etc.; R2 represents an alkyl group; n represents 0, 1 or 2, provided that when A1 and A2 both are —CH═, A3 represents —CH2— or —SO2—, which is an indole derivative or a mono- or diazaindole derivative that has COX-2 inhibitory activity and is useful as a pharmaceutical, such as an anti-inflammatory agent, or addition salts thereof with a pharmaceutically acceptable acid or base, or hydrates thereof.